Jounce Therapeutics, Inc. (JNCE): Price and Financial Metrics
Jounce Therapeutics, Inc. (JNCE)
Today's Latest Price: $6.82 USD
0.00 (0.00%)
Updated Nov 24 4:00pm
Add JNCE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
JNCE Stock Summary
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.19 for Jounce Therapeutics Inc; that's greater than it is for only 12.24% of US stocks.
- Over the past twelve months, JNCE has reported earnings growth of -175.29%, putting it ahead of just 11.2% of US stocks in our set.
- Revenue growth over the past 12 months for Jounce Therapeutics Inc comes in at 89.43%, a number that bests 94.05% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to Jounce Therapeutics Inc are DTIL, MGEN, GLYC, LPTX, and FULC.
- Visit JNCE's SEC page to see the company's official filings. To visit the company's web site, go to jouncetx.com.
JNCE Stock Price Chart Interactive Chart >
JNCE Price/Volume Stats
| Current price | $6.82 | 52-week high | $11.72 |
| Prev. close | $6.82 | 52-week low | $2.85 |
| Day low | $6.70 | Volume | 187,000 |
| Day high | $7.07 | Avg. volume | 594,017 |
| 50-day MA | $8.46 | Dividend yield | N/A |
| 200-day MA | $6.12 | Market Cap | 271.78M |
Jounce Therapeutics, Inc. (JNCE) Company Bio
Jounce Therapeutics, Inc. focuses on developing cancer immunotherapy treatments that enable the immune system to attack tumors. The company in 2012 and is based in Cambridge, Massachusetts.
Loading social stream, please wait...